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ABSTRACT 32 
In vitro and in vivo studies described the myokine IL-15 and its receptor IL-15Rα as 33 
anabolic/anti-atrophy agents, however the protein expression of IL-15Rα has not been measured 34 
in human skeletal muscle and data regarding IL-15 expression remain inconclusive. The 35 
purpose of the study was to determine serum and skeletal muscle IL-15 and IL-15Rα responses 36 
to resistance exercise session and to analyse their association with myofibrillar protein synthesis 37 
(MPS). Fourteen participants performed a bilateral leg resistance exercise composed of 4 sets of 38 
leg press and 4 sets of knee extension at 75% 1RM to task failure. Muscle biopsies were 39 
obtained at rest, 0, 4 and 24h post-exercise and blood samples at rest, mid-exercise, 0, 0.3, 1, 2, 40 
4 and 24h post-exercise. Serum IL-15 was increased by ~5.3-fold immediately post-exercise, 41 
while serum IL-15Rα decreased ~75% over 1h post-exercise (P<0.001). Skeletal muscle IL-42 
15Rα mRNA and protein expression were increased at 4h post-exercise by ~2-fold (P<0.001) 43 
and ~1.3-fold above rest (P=0.020), respectively. At 24h post-exercise IL-15 (P=0.003) and IL-44 
15Rα mRNAs increased by ~2-fold (P=0.002). Myofibrillar fractional synthetic rate between 0-45 
4h was associated with IL-15Rα mRNA at rest (r=0.662, P=0.019), 4h (r=0.612, P=0.029) and 46 
24h post-exercise (r=0.627, P=0.029). Finally, the muscle IL-15Rα protein up-regulation was 47 
related to Leg press 1RM (r=0.688, P=0.003) and total weight lifted (r=0.628, P=0.009). In 48 
conclusion, IL-15/IL-15Rα signalling pathway is activated in skeletal muscle in response to a 49 
session of resistance exercise. 50 
Keywords: Myokines, IL-15/IL-15Rα axis, strength training, muscle protein 51 
synthesis/breakdown.  52 
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INTRODUCTION 53 
Interleukin-15 (IL-15) and its cognate receptor alpha (IL-15Rα) have been implicated in the 54 
regulation of anabolic/catabolic balance of human skeletal muscle (Busquets et al., 2005; 55 
Furmanczyk & Quinn, 2003; Pistilli et al., 2007; Quinn et al., 2002; Quinn et al., 1995; 56 
Riechman et al., 2004). However, most of the evidence is indirect and the protein expression of 57 
IL-15Rα has not been determined in human skeletal muscle.  58 
IL-15 is a pleiotropic cytokine member of the 4 alpha-helix bundle family (Grabstein et 59 
al., 1994). IL-15 has been shown to stimulate protein accretion and myosin heavy chain (MHC) 60 
accumulation in differentiated myocytes (Quinn et al., 1995) and myotubes (Furmanczyk & 61 
Quinn, 2003; Quinn et al., 2002), while reducing protein degradation (Quinn et al., 2002). In 62 
humans, circulating IL-15 is elevated in response to a single session of resistance exercise in 63 
untrained and trained states (Riechman et al., 2004). In agreement with a muscular origin, IL-15 64 
mRNA was increased 2-fold in vastus lateralis muscle 24h after a bilateral leg press and knee 65 
extension resistance exercise session, although this was not accompanied by a change in 66 
circulating or muscular IL-15 protein expression (Nielsen et al., 2007). Therefore, despite the 67 
fact that in vitro studies indicate a role for skeletal muscle IL-15 in anabolism, studies in 68 
humans are inconclusive.  69 
 Although part of the effects of IL-15 are mediated by its binding to IL-15Rα (Dubois et 70 
al., 2002; Duitman et al., 2008; Sato et al., 2007), this alpha-receptor may also exert functions 71 
independent from IL-15 in skeletal muscle. IL-15Rα may have a role in determining the 72 
phenotype and fatigability of muscle fibers, and mitochondrial fuel utilization (Loro et al., 73 
2015; O'Connell et al., 2015; O'Connell et al., 2015). In addition, human studies indicate that 74 
IL-15Rα may be involved in muscle hypertrophy and strength gains after resistance training 75 
(Pistilli et al., 2008; Riechman et al., 2004). In this regard, two single nucleotide polymorphism 76 
(SNPs) in exon 7 and 4 of the IL-15Rα could explain part of the variability in the hypertrophy 77 
observed after 10 weeks of whole-body resistance training (Riechman et al., 2004), whereas IL-78 
15Rα SNPs, rs2296135 and rs22228059, were positively associated with pre- and post-exercise 79 
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isometric strength and muscle volume, respectively, after 12 weeks of resistance training of the 80 
flexor-extensor muscles of the elbow (Pistilli et al., 2008). 81 
Despite the potential implication of IL-15 and IL-15Rα in skeletal muscle 82 
anabolic/catabolic balance, direct evidence is lacking as no human study has determined 83 
whether changes in skeletal muscle IL-15Rα mRNA and protein expression are associated with 84 
protein synthesis. Recently, we reported a ∼2-fold elevated myofibrillar protein synthesis 85 
(MPS) response during the first four hours (0-4h) after a single session of resistance exercise in 86 
healthy young males (McKendry et al., 2016), however, skeletal muscle IL-15 and IL-15Rα 87 
were not determined. Therefore, the aim of this study was to determine whether circulating and 88 
skeletal muscle IL-15 and IL-15Rα might have a role in the regulation of myofibrillar protein 89 
synthesis, after a single session of resistance exercise.  90 
We hypothesised that skeletal muscle IL-15 and IL-15Rα expressions would be up-91 
regulated after a single session of resistance exercise and that IL-15 and IL-15Rα expression in 92 
skeletal muscle would be associated with myofibrillar protein synthesis. 93 
 94 
MATERIALS AND METHODS 95 
Participants 96 
A full description of the methods, study design and participant characteristics, from which part 97 
of current data are drawn, has been previously published (McKendry et al., 2016). Volunteers 98 
were aged from 18 to 35 years and had been participating in resistance training programmes > 2 99 
days/week during ≥ 1 year prior to start of current study. Subjects’ characteristics are presented 100 
in Table 1. Prior to study enrolment all procedures were explained to participants who then 101 
gave their written informed consent. Ethical approval was obtained through the NHS Black 102 
Country Research Ethics Committee (13/WM/0455) in accordance with the latest version (7
th
) 103 
of the Declaration of Helsinki. 104 
 105 
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Experimental design 106 
All participants reported to the School of Sport, Exercise and Rehabilitation Sciences 107 
(SportExR) laboratory on 3 separate occasions. During visit one, participants underwent 108 
preliminary assessments of body composition and maximal leg strength. Then, within a period 109 
of 8 days, the volunteers returned to the laboratory for the experimental trial, which consisted of 110 
a single session of bilateral lower-limb resistance exercise with muscle biopsies obtained at 111 
baseline, immediately after (0h), 4 and 24h post-exercise, and blood samples at baseline, mid-112 
exercise, and 0, 0.3, 1, 2, 4 and 24h post-exercise to assess the systemic and skeletal muscle 113 
responses of the IL-15/IL-15Rα axis. As part of the original investigation (McKendry et al., 114 
2016), participants were matched in pairs based on anthropometric, strength and training 115 
characteristics before to be randomly allocated to either 1-min or 5-min of passive rest between 116 
resistance exercise sets. Since no significant differences were observed in circulating or 117 
intramuscular IL-15 and IL-15Rα measurements between the 1-min (N = 7) and 5-min groups 118 
(N = 7), participants were treated as a single group for the purpose of the present analyses. Of 119 
the 16 participants included in the original study, 14 were analysed in the present investigation 120 
due to insufficient muscle tissue in the two subjects excluded. 121 
 122 
Experimental protocol 123 
A detailed description of the experimental protocol and analytical methods can be found 124 
elsewhere (McKendry et al., 2016). Briefly, regional and whole-body composition was 125 
determined by dual energy x-ray absorptiometry (Discovery DXA Systems, Hologic Inc., 126 
Bedford, MA, USA). Thereafter, one-repetition maximum (1RM) strength during leg press and 127 
knee extension was assessed (Cybex VR-3, MA, USA). Approximately seven days later 128 
participants reported to the laboratory at 07.00 hours being fasted for 10-12h. Upon arrival, a 129 
cannula was inserted into a forearm vein to obtain arterialised blood samples into a tube 130 
prepared for serum separation (BD, Oxford, UK). After resting supine in bed for 2.5h, a muscle 131 
biopsy was obtained from the vastus lateralis of one leg (~120mg of tissue) (Bergstrom, 1975), 132 
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under local anaesthesia (1% lidocaine). Skeletal muscle sample was cleaned from any fat or 133 
connective tissue before being frozen in liquid nitrogen. Following the muscle biopsy, 134 
participants completed a session of bilateral lower-extremity resistance exercise on leg press 135 
and knee extension machines. Exercise consisted of four sets of 8-15 repetitions per exercise at 136 
75% of 1RM, each set performed to task failure. At the end of the last repetition, a second 137 
muscle biopsy was obtained ~3 cm proximal from the first biopsy through a new incision. 138 
Immediately after the second biopsy, the volunteers ingested 25 g of whey protein isolate 139 
(MyProtein, Cheshire, UK) dissolved in 400 mL of water. During the next four hours, 140 
participants rested supine and then a third muscle biopsy was obtained from a new incision, ~3 141 
cm proximal to the second biopsy. The following morning at 7.00 h, participants returned to the 142 
laboratory after a 10-12h overnight fast and a cannula was inserted into a forearm vein to obtain 143 
a blood sample followed by the fourth and last biopsy, which was obtained from the vastus 144 
lateralis of the contralateral leg.  145 
 146 
The participants received three standardised meals for consumption the evening prior to 147 
the experimental trial, as well as the afternoon and evening after the experimental trial. The diet 148 
was composed by ~97 g of CHO (~58%), ~34 g of protein (~20%) and ~37 g of fat (~22%) 149 
with an energy content of ~871 kcal per meal. Consumption of ethanol or caffeine was not 150 
allowed 24h before the experiments neither during the study. 151 
 152 
Blood Analysis 153 
Serum IL-15 and IL-15Rα 154 
After collection, all blood samples were centrifuged for 15 minutes at 1000 g, aliquoted and 155 
stored at -80 ºC. Two high-sensitivity enzyme-linked immunosorbent assay (ELISA) kits were 156 
used to determine the serum concentration of IL-15 and IL-15Rα in duplicates. IL-15 was 157 
measured using Human IL-15 Quantikine ELISA kit (R&D Systems, MN, USA) recognizing 158 
both natural and recombinant human IL-15 (range: 0.49 – 62.5 pg/mL; intra- and inter-assay 159 
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coefficients of variation (CV) were 4.2 and 7.4%, respectively). Serum IL-15Rα was measured 160 
using Human IL-15 receptor subunit alpha ELISA kit (Wuhan EIAab Science, Wuhan, China) 161 
recognizing both natural and recombinant human IL-15Rα (range: 0.49 – 62.5 pg/mL; intra- 162 
and inter-assay CVs were 4.4 and 7.8%, respectively). 163 
 164 
Muscle Tissue Analysis 165 
Protein extraction and Western Blot procedures. 166 
Approximately 25-30 mg of muscle tissue was powdered on dry ice using a Cellcrusher
TM 
tissue 167 
pulveriser (Cellcrusher limited, Cork, Ireland) and a sucrose lysis buffer was used to prepare the 168 
samples for Western Blot as previously described (Philp et al., 2011). Equal amounts of protein 169 
(35 µg per sample) were boiled for 5 min in 1 x Laemmli sample buffer, separated on 10% 170 
SDS-PAGE gels (Bio-Rad, Copenhagen, Denmark) for 45 min and transferred to 171 
polyvinylidene difluoride (PVDF) membranes at constant voltage and 0.4 A for 1.5 h. 172 
Subsequently, membranes were incubated overnight with primary antibodies against IL-15 (sc-173 
7889) and IL-15Rα (sc-271366), purchased from Santa Cruz Biotechnology (Dallas, USA). 174 
Both antibodies were diluted into BSA-blocking buffer containing 4% bovine serum albumin in 175 
Tris-buffered saline with 0.1% Tween 20. Antibody specific labelling was revealed by 176 
incubation with an HRP-conjugated goat anti-rabbit (IL-15) or anti-mouse (IL-15Rα) antibodies 177 
(1:5000), both diluted in 5% blotto blocking buffer and visualised with ECL Western blotting 178 
detection system using a ChemiDoc XRS (Bio-Rad, Copenhagen, Denmark). Imaging and band 179 
quantification were performed using the Quantity One 1-D Analysis software (Bio-Rad, 180 
Copenhagen, Denmark). Test samples were run together with a control sample from a subject 181 
who did not take part in the study. The control sample was loaded in three different lanes and 182 
used as an internal control for inter-gel variability. Overall, the mean CVs of the controls were 183 
13.9% (IL-15) and 12.3% (IL-15Rα). Control samples and a total protein staining-technique 184 
method (reactive brown) were used to accurate protein quantification for loading control. 185 
 186 
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RNA Isolation and quantitative real-time reverse transcription polymerase chain reaction 187 
(qRT-PCR). 188 
Approximately 15-20 mg of skeletal muscle tissue was used for the RNA isolation. The RNA 189 
was extracted by guanine-phenol-chloroform isothiocyanate procedures using TRIzol 190 
(Invitrogen, Carlsbad, CA, USA). Then, RNA was recovered from the aqueous phase by 191 
precipitation; the amount and purity was measured by optical density at 260/280 nm and 192 
260/230 nm in a NanoDrop ND-100 spectrophotometer (Thermo Fisher Scientific Inc., DE, 193 
USA).  194 
 Reverse transcription was performed to synthesize cDNA from 200 ng of the total RNA 195 
using Oligo dT primers (GE Healthcare Bio-Sicences, Buckinghamshire, UK) and M-MLV 196 
reverse transcriptase enzyme (Invitrogen, Carlsbad, CA, USA). The cDNA was amplified using 197 
the primers presented in Table 2 (self-designed and tested in skeletal muscle from human 198 
donors, data not shown). The qRT-PCR mixture was composed by 5 µL of the inverse 199 
transcription product (cDNA) diluted 1:20, 10 µL of iQ SYBR Green Supermix (Bio-Rad, 200 
Copenhagen, Denmark) and 1 µL (6 mM) of the primer selected. The final reaction volume (20 201 
µL) was used to perform the qRT-PCR in a StepOnePlus Real-Time PCR System (Applied 202 
Biosystems, Foster City, CA, USA). All samples were subjected to an initial stage of 10 min at 203 
95ºC. The conditions for PCR amplification were as follows: 45 cycles of 95 ºC for 15 s, 60 ºC 204 
for 30 s and 72 ºC for 1 minute, for both IL-15 and IL-15Rα. Finally, mRNA expressions of IL-205 
15 and IL-15Rα were determined in triplicates, and normalized using β-actin and 206 
glyceraldehyde 3-phosphate-dehydrogenase (GAPDH) as housekeeping genes. β-actin and 207 
GAPDH expression remained unchanged. 208 
 209 
Myofibrillar and plasma tracer enrichment.  210 
Procedures for muscle myofibrillar protein isolation, plasma-free amino acid extraction and 211 
13
C6 phenylalanine enrichment, and calculation of myofibrillar fractional synthetic rate (FSR) at 212 
rest, 0-4h and 24-28h post-exercise are described in McKendry et al. (2016).   213 
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Briefly, a primed continuous infusion of L-[ring-
13
C6]phenylalanine (prime, 2 µmol kg
−1
; 214 
infusion, 0.05 µmol kg
−1
 min
−1
; Cambridge Isotope Laboratories, Andover, MA, USA) was 215 
implemented during both experimental trial days in conjunction with muscle biopsy and blood 216 
sampling. In both experimental days, the infusion was initiated immediately after the drawn of 217 
the first blood sample (~7.05 h) and finished when the last muscle biopsy sample of the day was 218 
obtained (7.5 h and 5.5 h after the beginning of the infusion on day 1 and 2, respectively). Upon 219 
thawing, plasma samples were purified on cation-exchange columns. The amino acids were 220 
then converted to their N-tert-butyldimethylsilyl-N-methyltrifluoracetamide (MTBSTFA) 221 
derivative. Plasma [
13
C6]phenylalanine enrichment was determined by gas chromatography–222 
mass spectrometry (GCMS; model 5973; Hewlett Packard, Palo Alto, CA, USA) by monitoring 223 
ions 234/240. The myofibrillar protein fraction was extracted and hydrolysed overnight. 224 
Constituent amino acids in the myofibrillar fraction were purified on cation-exchange columns. 225 
Amino acids in the myofibrillar fraction were then converted to their N-acetyl-n-propyl ester 226 
derivative. Plasma [
13
C6]phenylalanine enrichment was determined by gas chromatography–227 
mass spectrometry (GC-C-IRMS; Delta-plus XP; Thermofinnigan, Hemel Hempstead, UK) by 228 
monitoring ions 44/45. Pre-infusion and mean plasma [
13
C6]phenylalanine enrichment were 229 
used as a proxy for basal muscle protein enrichment and to determine an “estimated” 230 
intracellular precursor enrichment, respectively. The fractional synthesis rate (FSR) of the 231 
myofibrillar protein fraction was calculated from the incorporation of [
13
C6]phenylalanine into 232 
protein using the standard precursor-product model (Wolfe & Chinkes, 2005). 233 
 234 
Statistical Analysis 235 
Data collected in the study were analysed using the statistical package SPSS v. 22.0 (SPSS Inc., 236 
Chicago, IL, USA), and Graph Prism 6 (GraphPad software, Inc. La Jolla, CA, USA). Firstly, a 237 
Shapiro-Wilks was used to test the normality of the data (P > 0.05). Subsequently, non-238 
normally distributed variables were logarithmically transformed. Circulating and skeletal 239 
muscle expression of IL-15 and IL-15Rα were analysed between groups (1- vs. 5-min rest) 240 
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using a two-way, repeated measures ANOVA (time x condition). The area under the curve 241 
(AUC) was determined using trapezoid method and compared between groups using a paired 242 
Student’s t-test. Since no significant differences were observed between the 1- and 5-min 243 
recovery, both groups were combined for further analyses.  244 
 To determine time effects of the intervention on serum, protein and mRNA levels of IL-245 
15 and IL-15Rα, ANOVA for repeated measures was performed. Tukey HSD correction was 246 
used as post-hoc test when significant differences were detected. Finally, linear regression 247 
analysis was carried out to test the potential associations between skeletal muscle and 248 
circulating levels of IL-15 and IL-15Rα, as well as between the former and resistance training 249 
variables, body composition and myofibrillar FSR. The effect of size (ES) was calculated as eta 250 
squared statistic (η
2
) to verify time, condition and between groups differences in systemic and 251 
intramuscular IL-15 and IL-15Rα expression. Values are reported as mean ± standard deviation 252 
(SD); a P < 0.05 was considered statistically significant. 253 
 254 
RESULTS 255 
Variables describing the resistance exercise session performed by the subjects are presented in 256 
Table 3. 257 
 258 
IL-15 response to a single dose of resistance exercise. 259 
Skeletal muscle mRNA and protein expression levels, and serum IL-15 concentrations in 260 
response to a single session of resistance exercise are illustrated in Figure 1. A progressive 261 
increase in mRNA expression was found following resistance exercise (P = 0.002, ES = 0.35), 262 
reaching statistical significance at 4h (P = 0.019, ES = 0.37) and 24h post-exercise, where a 2-263 
fold elevation above pre-exercise resting values was found (P = 0.003, ES = 0.44; Fig. 1A). No 264 
significant changes were observed in IL-15 muscle protein expression above pre-exercise 265 
resting values (P = 0.563, ES = 0.15; Fig. 1B). Serum IL-15 concentration increased 266 
significantly above pre-exercise resting values during the post-exercise period (P = 0.001, ES = 267 
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0.46; Fig. 1C), peaking immediately post-exercise (P < 0.001, ES = 0.31), and remaining 268 
elevated at 24h post-exercise (P = 0.001, ES = 0.42). 269 
 270 
IL-15Rα response to a single dose of resistance exercise.   271 
Skeletal muscle mRNA and protein expression levels, and serum IL-15Rα concentration in 272 
response to a single session of resistance exercise are illustrated in Figure 2. A significant 2-273 
fold increase in IL-15Rα mRNA expression above pre-exercise resting values was observed at 274 
4h (P < 0.001, ES = 0.42) and 24h post-exercise (P = 0.002, ES = 0.35; Fig. 2A). In contrast to 275 
IL-15, skeletal muscle protein expression of IL-15Rα increased by 1.3-fold (P = 0.020, ES = 276 
0.34; Fig. 2B) above pre-exercise resting values at 4h post-exercise, returning to baseline levels 277 
24h post-exercise (P = 0.036, ES = 0.32). Despite of the lack of significant differences between 278 
inter-set rest period (1- vs. 5-min groups), the 5-min group tended to show an elevated protein 279 
and mRNA expression at 4h and post-exercise (~10%; P = 0.103, ES = 0.55 and P = 0.092, ES 280 
= 0.57, respectively; supplementary figure 2). Finally, compared to pre-exercise values, serum 281 
IL-15Rα concentration was significantly reduced during the first 60 min following the training 282 
session (P < 0.001; ES = 0.47; Fig. 2C). 283 
 284 
Correlation analysis 285 
IL-15/IL-15Rα and resistance exercise variables. 286 
Leg Press 1RM strength was negatively associated with IL-15 serum concentration (r = -0.800, 287 
P = 0.003) but not with IL-15Rα serum concentration. While the serum IL-15 concentration 288 
response to resistance exercise (AUC) was negatively associated with knee extension training 289 
volume (r = -0.637, P = 0.042) and time-under-tension (T-U-T) (r = -0.718, P = 0.019). Post-290 
exercise (0h), serum IL-15 concentrations were associated with the total volume of knee 291 
extension exercise (r = -0.934, P < 0.001). Furthermore, skeletal muscle protein expression of 292 
IL-15Rα at 4h post-exercise was associated positively with 1RM Leg press strength (r = 0.559, 293 
P = 0.037) and total training load (r = 0.628, P = 0.009). 294 
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 295 
Skeletal muscle and circulating expressions of IL-15/IL-15Rα 296 
At baseline, serum IL-15 concentration was positively associated with intramuscular protein IL-297 
15 levels (r = 0.649, P = 0.031), but not with mRNA expression. Serum IL-15 immediately 298 
post-exercise was associated with pre-exercise levels of skeletal muscle protein expression of 299 
IL-15 and IL-15Rα (r = 0.582, P = 0.037; r = -0.599, P = 0.031, respectively). At baseline, IL-300 
15 mRNA was associated with IL-15Rα mRNA (r = 0.592, P = 0.043), as well as immediately 301 
(r = 0.791, P = 0.005) and 24h post-exercise (r = 0.653, P = 0.021). Additionally, IL-15 and IL-302 
15Rα mRNA expressions at 24h post-exercise was negatively associated with serum 303 
concentration of IL-15 and IL-15Rα (r = -0.620, P = 0.042; r = -0.727, P = 0.005; respectively). 304 
 305 
Skeletal muscle IL-15/IL-15Rα expression and myofibrillar protein synthesis.  306 
The myofibrillar fractional synthetic rate (FSR) increased by ~2-fold above resting values from 307 
0-4h post-exercise (McKendry et al., 2016) and was associated with IL-15Rα mRNA levels at 308 
baseline (r = 0.662, P = 0.019), 4h (r = 0.612, P = 0.029) and 24h post-exercise (r = 0.627, P = 309 
0.029) (Figure 3). Moreover, the delta changes (∆), from pre-exercise to 4h post-exercise, of IL-310 
15Rα mRNA expression and FSR showed a tendency to be associated at 4h post-exercise (r = 311 
0.481; P = 0.096). No association was observed between myofibrillar FSR and skeletal muscle 312 
IL-15 mRNA or muscle protein expression of either IL-15 or IL-15Rα at any time. 313 
 314 
DISCUSSION 315 
The present study demonstrates that the gene and protein expression of IL-15Rα is up-regulated 316 
in skeletal muscle after a single session of resistance training. The increase in myofibrillar 317 
protein synthesis during 0-4h post-exercise was associated with the expression of IL-15Rα 318 
mRNA at 4h, which occurred concomitantly with an increase of skeletal muscle IL-15Rα 319 
protein levels, suggesting increased translation of the IL-15Rα gene. These findings indicate 320 
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that IL-15Rα could have a role in mediating the increase in myofibrillar protein synthesis 321 
observed in skeletal muscle after a single session of resistance training.  322 
Although, in our previous study we demonstrated that myofibrillar protein synthesis rates 323 
were greater when high volume, moderate-intensity resistance exercise was performed with 324 
long (5-min) compared with short (1-min) inter-set rest duration (McKendry et al., 2016), in the 325 
present study, we did not observe significant differences between groups in circulating or 326 
intramuscular IL-15 and IL-15Rα expressions, despite skeletal muscle IL-15Rα tended to be 327 
elevated in the 5-min compared to the 1-min group (supplementary figure 2). This lack of 328 
differences could be interpreted as evidence to refute the association between skeletal muscle 329 
IL-15/IL-15Rα and MPS. Nevertheless, the effect sizes and statistical outputs (P<0.10) indicate 330 
that a potential difference between groups may actually exist. This suggestion is also supported 331 
by the fact that the association between IL-15Rα and MPS in the early recovery phase (0-4h 332 
post-exercise) was observed in each group separately (1-min group, r
 
= 0.592, P = 0.052; and 5-333 
min, r
 
= 0.684, P = 0.043). Therefore, our results provide the framework for future studies to 334 
further clarify whether the IL-15/IL-15Rα response to strength training reported here have a 335 
physiologically relevant role in human skeletal muscle adaptation to this type of exercise. 336 
 337 
The interleukin-15 subunit alpha-receptor (IL-15Rα) is a key subunit receptor of IL-15 338 
that regulates its signalling in several cell types (Budagian et al., 2006; Dubois et al., 2002; 339 
Duitman et al., 2008; Sato et al., 2007). In addition to the common receptor-binding functions, 340 
IL-15Rα has been shown to function by itself, without the need for IL-15 binding (Loro et al., 341 
2015; O'Connell et al., 2015; Pistilli et al., 2011; Pistilli et al., 2013). Animal experiments have 342 
shown that IL-15Rα is necessary to maintain insulin sensitivity, since mice lacking IL-15Rα are 343 
hyperglycemic and insulin-resistant, despite increased oxidative capacity and reduced fat mass 344 
(Loro et al., 2015). Furthermore, gene-deletion of IL-15Rα in mice is accompanied by enhanced 345 
fatigue resistance and a glycolytic-to-oxidative shift in muscle phenotype (O'Connell et al., 346 
2015; Pistilli et al., 2011). It has been demonstrated that strength training promotes a muscle 347 
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myosin heavy chain expression shift from IIx to IIa (Andersen et al., 2005; Campos et al., 2002; 348 
Pareja-Blanco et al., 2016), increasing fatigue resistance. However, it remains unknown 349 
whether IL-15Rα up-regulation contributes to this shift in fiber types (from IIx to IIa) with 350 
training in humans. In support of this notion, those participants with a higher IL-15Rα protein 351 
expression at 4h post-exercise in our study, performed a greater volume of resistance exercise 352 
and had a higher baseline leg press 1RM. Thus, the up-regulation of IL-15Rα could serve as an 353 
adaptive response to maintain muscle characteristics associated with force production. Indeed, 354 
others have reported that two SNPs in exon 7 and 4 of the IL-15Rα were able to explain a ~11% 355 
of the hypertrophy observed after 10 weeks of whole-body resistance exercise in 157 young 356 
adults (Riechman et al., 2004). Similarly, another two SNPs, rs2296135 and rs22228059, have 357 
been associated with isometric strength and muscle volume before and after 12 weeks of 358 
unilateral elbow flexor-extensor resistance exercise (Pistilli et al., 2008).  359 
Overexpression of IL-15 has revealed that the anabolic/anti-atrophic action of this 360 
interleukin is associated with decreased skeletal muscle proteolysis (Busquets et al., 2005) and 361 
apoptosis through suppression of DNA fragmentation via tumour necrosis factor alpha (TNF-α) 362 
signalling (Figueras et al., 2004). Moreover, IL-15Rα mRNA expression is reduced with aging, 363 
and may underpin skeletal muscle atrophy in mice (Marzetti et al., 2009). In agreement, we 364 
have observed an association between IL-15Rα mRNA and MPS in the early recovery phase 365 
following resistance exercise. Interestingly, concomitant with the elevation of MPS and IL-366 
15Rα mRNA expression, an up-regulation of IL-15Rα protein was also found at 4h post-367 
exercise, suggesting that IL-15Rα may have a role in the induction or maintenance of the 368 
anabolic stimulus during the early post-exercise recovery phase, potentially counteracting the 369 
degree of protein breakdown (Phillips et al., 1997). However, further studies are required to 370 
delineate the role of IL-15Rα in exercise-induced muscle remodelling. 371 
In contrast to the response observed in skeletal muscle, serum IL-15Rα was slightly 372 
reduced at 60 min post-exercise. The discordance between the circulating and skeletal muscle 373 
IL-15Rα response to resistance exercise could imply a counteracting mechanism, by which IL-374 
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15Rα binding of IL-15, in blood or cell membrane, reduces its availability (Rubinstein et al., 375 
2006; Schluns et al., 2005) and potentially allows its reabsorption and subsequent restoration of 376 
the intracellular pool of free IL-15.  377 
Although pioneer cell culture studies reported an anabolic effect of IL-15 (Quinn et al., 378 
2002; Quinn et al., 1997; Quinn et al., 1995), this has not been confirmed in humans. Strength 379 
training-induced muscle hypertrophy is limited to the trained muscles, implying that the 380 
anabolic action of IL-15 in human skeletal muscle cannot be explained by an increase in the 381 
circulating fraction of this myokine. In fact, human experiments do not give support to an 382 
anabolic action of IL-15 in skeletal muscle (Nielsen et al., 2007; Riechman et al., 2004). 383 
However, the physiological relevance of the 24h post-exercise elevation of IL-15 gene 384 
expression in response to resistance exercise, as reported in the present and previous studies 385 
(Nielsen et al., 2007), although suggestive of a role of IL-15 in exercise-induced skeletal muscle 386 
adaptation, remains largely unexplained. The lack of association found between the increase in 387 
IL-15 mRNA at 24h post-exercise and MPS does not support a critical anabolic role, but to 388 
definitely rule out such effect would require the utilization of IL-15 blockers or antibodies, 389 
which cannot be used in humans due to potentially intolerable immunological side effects. 390 
Moreover, the anti-atrophic effect of IL-15 in skeletal muscle has not been tested in the present 391 
study and cannot be excluded (Busquets et al., 2005; Marzetti et al., 2009).  392 
 393 
Interleukin-15 is currently considered as a myokine (Grabstein et al., 1994; Quinn et al., 394 
1995). In agreement, we have observed a positive association between serum concentration of 395 
IL-15 and IL-15 protein levels in skeletal muscle, suggesting that muscle may be an important 396 
source of IL-15 in the basal state. In the present study, we observed that basal IL-15 protein 397 
levels in skeletal muscle were associated with serum concentration immediately post-exercise, 398 
also suggesting that the size of the intramuscular pool could determine the magnitude of the 399 
increase in serum IL-15 elicited by resistance exercise. Nevertheless, the physiological 400 
Page 16 of 32
Scandinavian Journal of Medicine & Science in Sports - PROOF
Scandinavian Journal of Medicine & Science in Sports - PROOF
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
PROOF
 16
relevance of the elevated blood IL-15 concentration in close proximity to the end of exercise 401 
remains to be elucidated (Riechman et al., 2004; Tamura et al., 2011). 402 
Interestingly, we found that a lower time-under-tension and a lower amount of total 403 
weight lifted during resistance exercise session were associated with higher post-exercise serum 404 
IL-15 concentration, which could indicate that a more prolonged muscle activation may 405 
attenuate the release of IL-15. Depletion of the intracellular pool or reduced de novo synthesis 406 
of IL-15 could explain the attenuated release of IL-15 with greater training load, given the short 407 
life of IL-15 in plasma (Rubinstein et al., 2006; Stoklasek et al., 2006). 408 
 The fact that the increase of circulating IL-15 was not accompanied by an increase in its 409 
soluble receptor implies that after resistance training there is more free IL-15, available to act 410 
on target tissues (Mortier et al., 2004). IL-15 is a potent pro-inflammatory cytokine that 411 
stimulates proliferation, maturation and has protective effects on several immune cells 412 
(Budagian et al., 2006). In addition to the immunological effects, IL-15 has anti-adipogenic 413 
effects in rodents (Carbo et al., 2001). Therefore, although the physiological role of the 414 
systemic elevation of IL-15 in response to strength training remains unknown, immunological 415 
and metabolic effects are possible.  416 
 417 
 In conclusion, the IL-15/IL-15Rα signalling pathway is activated in human skeletal 418 
muscle in response to a single session of resistance exercise. Skeletal muscle mRNA levels and 419 
protein IL-15Rα expression were elevated four hours after resistance exercise and were 420 
positively associated with increased rates of myofibrillar protein synthesis. Therefore, as 421 
previously shown in cell culture and in vivo, the present investigation lends support to a 422 
potentially anabolic effect of IL-15Rα in human skeletal muscle. Moreover, our experimental 423 
results indicate that IL-15 and IL-15Rα may play a role in exercise-induced muscle 424 
remodelling. Prolonged resistance training studies are necessary to determine the relevance of 425 
IL-15Rα in muscle protein synthesis/breakdown, as well as the precise role of circulating and 426 
muscular levels of IL-15 and its receptor IL-15Rα in chronic physiological adaptations.  427 
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 428 
Perspectives 429 
Previous studies have suggested a role of IL-15Rα in muscle phenotypic adaptation to 430 
resistance training. The present study confirms the activation of IL-15/IL-15Rα signalling 431 
pathway in human skeletal muscle in response to a single session of resistance exercise. It 432 
remains to be determined how skeletal muscle contributes to circulating levels of IL-15 and 433 
how circulating IL-15 could influence skeletal muscle and adipose tissue mass. Given the 434 
important role that IL-15 has in immune responses, the link between physical activity, skeletal 435 
muscle IL-15 production and immunity deserves further attention. The fact that IL-15Rα is 436 
independently associated with myofibrillar protein synthesis and muscle phenotype implies that 437 
the axis IL-15/ IL-15Rα may have an important role in human skeletal muscle remodelling. 438 
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FIGURE LEGENDS 564 
 565 
Figure 1. IL-15 response to a single session of resistance exercise.  566 
IL-15 mRNA (qRT-PCR) (A) and protein levels (Western blotting) (B) from vastus lateralis 567 
muscle biopsies, and serum IL-15 levels (ELISA) (C). Values are presented as means ± SD (N 568 
= 14). * P<0.05 compared to Pre-exercise. # P<0.05 compared to 0h post-exercise. Data were 569 
log-transformed. 570 
 571 
Figure 2. IL-15Rα response to a single session of resistance exercise.  572 
IL-15Rα mRNA (qRT-PCR) (A) and protein levels (Western blotting) (B) from vastus lateralis 573 
muscle biopsies, and serum IL-15Rα levels (ELISA) (C). Values are presented as means ± SD 574 
(N = 14). * P<0.05 compared to Pre-exercise. # P<0.05 compared to 0h post-exercise. Φ 575 
P<0.05 compared to 24h post-exercise. § P<0.05 differences compared to Mid-exercise. Data 576 
were log-transformed. 577 
 578 
Figure 3. Relationship between myofibrillar protein synthesis measured as a fractional 579 
synthetic rate (FSR) and IL-15Rα mRNA pre- and post-exercise. The association remained 580 
significant in Fig. 3B (r = 0.665, P = 0.026) when the lowest FSR values were excluded. a.u., 581 
arbitrary units.  582 
 583 
Supplementary Figure 1. Skeletal muscle IL-15 response to a single session of resistance 584 
exercise by group (1 and 5 min groups).  585 
IL-15 mRNA (qRT-PCR) (A) and protein levels (Western blotting) (B) from vastus lateralis 586 
muscle biopsies. Values are presented as means ± SD (N = 14). * P<0.05 compared to Pre-587 
exercise. Data were log-transformed. a.u., arbitrary units. 588 
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Supplementary Figure 2. Skeletal muscle IL-15Rα response to a single session of resistance 589 
exercise by group (1 and 5 min groups).  590 
IL-15Rα mRNA (qRT-PCR) (A) and protein levels (Western blotting) (B) from vastus lateralis 591 
muscle biopsies. Values are presented as means ± SD (N = 14). * P<0.05 compared to Pre-592 
exercise. # P<0.05 compared to 0h post-exercise. Data were log-transformed. a.u., arbitrary 593 
units. 594 
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Table 1. Participants’ physical characteristics 
 
 
 
 
 
 
 
 
 
 
Values are presented as mean ± SD. BMI, body 
mass index; FFM, fat free mass; FM, fat mass; 1RM, 
one-repetition maximum.  
N 14 
Age (yrs) 24.9 ± 4.8 
Body mass (kg) 82.2 ± 11.9  
BMI (kg/m2) 25.6 ± 3.1 
Whole-body FFM (kg) 66.0 ± 8.8 
Legs FFM (kg) 21.5 ± 3.2 
Whole-Body FM (kg) 12.9 ± 5.2 
Legs FM (kg) 4.5 ± 1.5 
Leg Press 1-RM (kg) 268 ± 51 
Knee Extension (kg) 169 ± 26  
Training experience (yrs) 6 ± 5 
Leg training (days/week) 2 ± 1 
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Table 2.  Primers for qRT-PCR analysis. 1 
Tm, melting temperature.  2 
Primer Sequence Accession Number Tm 
    
IL-15 F: 5'-AAAGTGATGTTCACCCCAGTTG 
R: 3'-CCTCCAGTTCCTCACATTCTTTG 
NM_000585.4 60º 
30s 
    
IL-15Rα F: 5'-CAGCCGCCAGGTGTGTATC 
R: 3'-TTGCCTTGACTTGAGGTAGCA 
NM_002189.3 60º 
30s 
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Table 3. Variables describing the resistance session. 1 
Values are presented as mean ± SD. T-U-T, time-under-tension; RPE, rating of perceived exertion.  2 
 Leg Press  Knee Extension  Total  
Set 1 2 3 4 Total 
 
1 2 3 4 Total  8  
Load (kg) 205±40  205±39 205±38 206±37 820±154 
 
123±18 119±19 117±19 114±18 473±73  1293±210   
Repetition 13±3  11±2 11±2 10±2 44±6 
 
9±2 9±2 10±2 9±2 37±6  10±1  
Volume (kg) 2484±401 2188±296 2260±452  2019±533 8951±1217 
 
1068±276 1119±296 1139±323 1081±352 4407±1127  13358±2026  
T-U-T (s) 38.3±11.5 34.4±7.1 33.1±6.2 32.9±5.9 138.7±27.4 
 
23.7±9.5 18.8±3.4 19.2±4.7 18.9±3.1 80.6±17.2  219.4±40.8  
RPE (0-10) 9±1 9±1 10±0  10±1 9±0 
 
10±0  10±0 10±0 10±0 10±0  10±0  
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